The latest update is out from Cyteir Therapeutics (CYT).
Following a previously approved liquidation plan, a company has taken a significant step towards dissolution by filing a Certificate of Dissolution with the Delaware Secretary of State. This action marks the company’s formal disbandment and sets March 20, 2024, as the date for identifying shareholders eligible for asset distributions, estimated between $3.10 and $3.16 per share. The company’s common stock transfers have ceased, with the first payout expected in the second quarter of 2024.
For detailed information about CYT stock, go to TipRanks’ Stock Analysis page.
